Overview

• GenePoweRx and MGI Tech announced a co-marketing partnership on June 11 to combine genomic sequencing with AI-based analytics.
• The collaboration aims to revolutionize predictive healthcare, precision medicine and longevity science by offering rapid, clinical-grade genomic services.
• The joint platform targets over 100 chronic and lifestyle-related conditions, including cardiovascular disease, diabetes, hereditary cancers and drug response profiling.
• GenePoweRx will contribute its AI/ML-driven bioinformatics engine and population-scale genomics research to generate personalized risk reports and nutrigenomic insights.
• MGI Tech will supply scalable, clinical-grade sequencers and leverage its global distribution network to expand access to advanced genomic diagnostics worldwide.